Hospital/Health-System Pharmacy Here's what docs don't know about diabetes patients August 01, 2016 By Tracey Walker Surveys conducted by the AACE with support from Sanofi US, identified differences in perceptions among adults living with type 2 diabetes. What healthcare professionals don't know may surprise you. HHS tackles opioid epidemic July 09, 2016 By Tracey Walker HHS is taking formal steps to address opioid addiction, a widely recognized national public health crisis. Find out the policy changes. Antibiotic stewardship programs: 4 case studies July 06, 2016 By Tracey Walker All antibiotic use has the potential to contribute to the development of antibiotic resistance. That’s why it is key to reduce inappropriate antibiotic use in order to slow the growth of resistance. How health plans can derail ER care costs June 16, 2016 By Tracey Walker The ER Savings Initiative is designed to deliver care in a hybrid model that collaborates with health systems to eliminate the unnecessary use and costs of their ERs. New agreement supports value-based pharma contracting June 01, 2016 By Tracey Walker Industry experts are using their proprietary data/analysis to help structure contracts between pharmaceutical companies and plans. Four critical components for successful, value-based pharma contracts June 01, 2016 By Marc O'Connor Despite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction. Will price impede recently approved implant for opioid addicts? May 26, 2016 By Tracey Walker Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way. Proposed Medicare Part B rule would cut payments for some drugs April 25, 2016 By Tracey Walker New analysis finds proposed Medicare payment changes for physician-administered drugs would reduce reimbursement for those that cost more than $480 per day in 2016. Seven of the 10 drugs that constitute the largest reduction in reimbursement are used to treat cancer. Shaping specialty pharmacy’s future: 4 perspectives April 20, 2016 By Mari Edlin At AMCP, four stakeholders representing the specialty pharmacy perspective, manufacturer perspective, payer perspective, and PBM perspective shared their thoughts on the future of specialty pharmacy. AMCP Annual Meeting highlights specialty pharmaceutical challenges April 18, 2016 By Susan A. Cantrell The CEO of the Academy of Managed Care Pharmacy identifies key challenges and opportunities that will be discussed at the annual meeting.